Our research in 2024: How we made a difference together
We have some big and exciting plans for 2025, and we are looking forward to getting started. But first, let's look all the amazing things that your support has helped achieve this year...
We have some big and exciting plans for 2025, and we are looking forward to getting started. But first, let's look all the amazing things that your support has helped achieve this year...
Children’s Cancer and Leukaemia Group (CCLG) has funded a new research project investigating the long-term effects of childhood leukaemia treatment on developing brains.
Targeting treatments to cancer cells is a key goal of childhood cancer research. After all, why wouldn’t you want your treatment to only harm the thing you want to fight?
Children’s Cancer and Leukaemia Group (CCLG) has funded two vital new research projects to improve patients’ quality of life after childhood cancer treatment.
Children’s Cancer and Leukaemia Group (CCLG) has funded a new lymphoma research project, thanks to five fundraising families.
Each year in the UK 1,900 children are diagnosed with cancer and it’s the biggest cause of death by disease in children aged 0-14 years. One in 300 children will develop cancer by the age of 18. Despite this, many children experience long waits for diagnosis, contributing to treatment delays and their cancer being diagnosed when it’s much harder to treat.
The CCLG Research Discovery Day on 1 October, at The University of Leeds, welcomed parents of children diagnosed with cancer, survivors and fundraisers, who heard top experts share ongoing research aimed at improving the future for children and young people with cancer.
We talked to Scott to find out how he is using his experiences of childhood cancer to improve research and advocate for the voices of patients.
A vital new research project funded by a Children's Cancer and Leukaemia Group (CCLG) Special Named Fund will investigate the effects of radiotherapy and chemotherapy on children's developing brains.